EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mesenchymal Stem Cell-Extracellular Vesicle Therapy for Stroke: Scalable Production and Imaging Biomarker Studies

Jeong Pyo Son, Eun Hee Kim, Eun Kyoung Shin, Dong Hee Kim, Ji Hee Sung, Mi Jeong Oh, Jae Min Cha, Michael Chopp, Oh Young Bang iD

Stem Cells Translational Medicine · 2023

DOI: 10.1093/stcltm/szad034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Jeong Pyo Son und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul,…. Hauptthemen laut MEDLINE: Stroke, Extracellular Vesicles, MicroRNAs, Mesenchymal Stem Cells. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Technology Innovation Program, Ministry of Trade, Industry & Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major clinical hurdle to translate MSC-derived extracellular vesicles (EVs) is the lack of a method to scale-up the production of EVs with customized therapeutic properties. In this study, we tested whether EV production by a scalable 3D-bioprocessing method is feasible and improves neuroplasticity in animal models of stroke using MRI study. MSCs were cultured in a 3D-spheroid using a micro-patterned well. The EVs were isolated with filter and tangential flow filtration and characterized using electron microscopy, nanoparticle tracking analysis, and small RNA sequencing. Compared to conventional 2D culture, the production-reproduction of EVs (the number/size of particles and EV purity) obtained from 3D platform were more consistent among different lots from the same donor and among different donors. Several microRNAs with molecular functions associated with neurogenesis were upregulated in EVs obtained from 3D platform. EVs induced both neurogenesis and neuritogenesis via microRNAs (especially, miR-27a-3p and miR-132-3p)-mediated actions. EV therapy improved functional recovery on behavioral tests and reduced infarct volume on MRI in stroke models. The dose of MSC-EVs of 1/30 cell dose had similar therapeutic effects. In addition, the EV group had better anatomical and functional connectivity on diffusion tensor imaging and resting-state functional MRI in a mouse stroke model. This study shows that clinical-scale MSC-EV therapeutics are feasible, cost-effective, and improve functional recovery following experimental stroke, with a likely contribution from enhanced neurogenesis and neuroplasticity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeExtracellular VesiclesMicroRNAsMesenchymal Stem CellsAnimalsMiceDiffusion Tensor ImagingBiomarkers

Stichwörter der Autor:innen

extracellular vesiclesmagnetic resonance imagingneurogenesisstem cellsstroke

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
  • Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, South Korea.
  • Accelerator Radioisotope Research Section, Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Research Institute (KAERI), Jeongeup, South Korea.
  • R&D Division, S&E bio Co., Ltd., Seoul, South Korea.
  • 3D Stem Cell Bioprocessing Laboratory, Department of Mechatronics, Incheon National University, Incheon, South Korea.
  • Department of Neurology, Henry Ford Health System, Detroit, MI, USA.

ORCID-Profile: Oh Young Bang

Förderung

  • Technology Innovation Program
  • Ministry of Trade, Industry & Energy

Zitieren

APA

Son, J. P., Kim, E. H., Shin, E. K., Kim, D. H., Sung, J. H., Oh, M. J., Cha, J. M., Chopp, M., & Bang, O. Y. (2023). Mesenchymal Stem Cell-Extracellular Vesicle Therapy for Stroke: Scalable Production and Imaging Biomarker Studies. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad034

Vancouver

Son JP, Kim EH, Shin EK, Kim DH, Sung JH, Oh MJ, et al. Mesenchymal Stem Cell-Extracellular Vesicle Therapy for Stroke: Scalable Production and Imaging Biomarker Studies. Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szad034

BibTeX
@article{Son2023,
  author = {Son, Jeong Pyo and Kim, Eun Hee and Shin, Eun Kyoung and Kim, Dong Hee and Sung, Ji Hee and Oh, Mi Jeong and Cha, Jae Min and Chopp, Michael and Bang, Oh Young},
  title = {Mesenchymal Stem Cell-Extracellular Vesicle Therapy for Stroke: Scalable Production and Imaging Biomarker Studies},
  journal = {Stem Cells Translational Medicine},
  year = {2023},
  doi = {10.1093/stcltm/szad034}
}
Kostenlos starten →